Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prospects for immunotherapy.

M F Woodruff

    Developments in Biological Standardization
    |April 13, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Exploring novel cancer treatments, this research highlights the potential of immunotherapy despite limited clinical success. Future trials need better design to overcome challenges like patient tumor burden and improve outcomes.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Tumour-association transplantation antigens.

    Immunology today·2014
    Same author

    The Outlook for Transplantation of the Kidney in Man.

    Proceedings of the Royal Society of Medicine·2009
    Same author

    Tissue Transplantation.

    Proceedings of the Royal Society of Medicine·2009
    Same author

    Transplantation and cancer control: a lifetime of research.

    Proceedings of the Royal College of Physicians of Edinburgh·1992
    Same author

    Immunosurveillance.

    Current opinion in immunology·1989
    Same author

    The role of immunology in the development of clinical transplantation.

    Immunology letters·1989
    Same journal

    International challenges and public policy issues.

    Developments in biological standardization·2000
    Same journal

    Regulation of biologicals in China.

    Developments in biological standardization·2000
    Same journal

    ICH activities on biotech topics.

    Developments in biological standardization·2000
    Same journal

    Regulation of biologicals in the European Union.

    Developments in biological standardization·2000
    Same journal

    Standardisation and licensing of combination vaccines based on DTP.

    Developments in biological standardization·2000
    Same journal

    Control of foot-and-mouth disease by vaccination.

    Developments in biological standardization·2000
    See all related articles

    Area of Science:

    • Oncology
    • Immunology
    • Clinical Trials

    Background:

    • Conventional cancer treatments have limitations, necessitating the exploration of new therapeutic strategies.
    • Immunotherapy, despite recent criticisms, remains a compelling approach based on strong theoretical and experimental foundations.
    • Current clinical benefits from immunotherapy are limited, partly due to suboptimal trial design and significant patient tumor burden.

    Purpose of the Study:

    • To evaluate the potential of immunotherapy as a novel cancer treatment.
    • To identify factors contributing to the limited success of current immunotherapeutic approaches.
    • To propose improvements in clinical trial design for more effective immunotherapy research.

    Main Methods:

    • Review of existing theoretical and experimental data on cancer immunotherapy.

    Related Experiment Videos

  • Analysis of factors influencing clinical outcomes in immunotherapy trials, including trial design and patient selection.
  • Formulation of recommendations for future immunotherapy research.

    • Main Results:

    • Immunotherapy shows promise based on established scientific principles and experimental evidence.
    • Suboptimal clinical trial design and advanced disease stages in patients have hindered the demonstration of immunotherapy efficacy.
    • A significant gap exists between the theoretical potential of immunotherapy and its current clinical application.

    Conclusions:

    • Further research and development in cancer immunotherapy are warranted.
    • Improved, well-controlled clinical trials are crucial for realizing the therapeutic potential of immunotherapy.
    • Future research should focus on optimizing trial design and patient selection to overcome existing challenges and achieve meaningful clinical benefits.